Reoperative Surgical Aortic Valve Replacement Versus Transcatheter Valve-in-Valve Replacement for Degenerated Bioprosthetic Aortic Valves Julius I. Ejiofor,

Slides:

Advertisements

Similar presentations

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Advertisements

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

“Double-Stick” Transsubclavian Transcatheter Aortic Valve Replacement With Use of a Balloon Expandable Valve: A Less Invasive Option for Alternative Access

Benny Weksler, MD, Jennifer L. Sullivan, MD

Reoperative aortic valve replacement in the octogenarians—minimally invasive technique in the era of transcatheter valve replacement Tsuyoshi Kaneko,

Reply The Annals of Thoracic Surgery

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Outcomes of Reintervention on the Autograft After Ross Procedure

Aortic Atheroma Increases the Risk of Long-Term Mortality in 20,000 Patients Carolyn Goldberg Butler, MD, Jamahal Maeng Ho Luxford, MBBS, FANZCA, Chuan-Chin.

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Operative Results and Outcomes in Children With Shone's Anomaly

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension Ramdas G. Pai, MD, Padmini Varadarajan,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement Hyun-Chel Joo, MD,

Long-Term Outcomes of the Mosaic Bioprosthesis

Postoperative Recurrence of Mitral Regurgitation After Annuloplasty for Functional Mitral Regurgitation Lawrence S. Lee, MD, Michael H. Kwon, MD, Marisa.

Durability of Homografts Used to Treat Complex Aortic Valve Endocarditis Willem Flameng, MD, PhD, Willem Daenen, MD, Ramadan Jashari, MD, Paul Herijgers,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis

Sam Chitsaz, MD, Nicolas Jaussaud, MD, Edward Chau, MD, Kimberly S

Expanding Indications for Valve-Sparing Aortic Root Reconstruction: Early and Midterm Results Johanna Valo, BM, Janne J. Jokinen, MD, PhD, Markku Kaarne,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Learning Alternative Access Approaches for Transcatheter Aortic Valve Replacement: Implications for New Transcatheter Aortic Valve Replacement Centers

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Transcatheter Aortic Valve Replacement: How I Teach It

Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: A propensity-matched analysis

Percutaneous Transcatheter Closure of the Aortic Valve

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Redo Aortic Valve Replacement in Children

Aortic and Mitral Valve Replacement Versus Transcatheter Aortic Valve Replacement in Propensity-Matched Patients Fenton H. McCarthy, MD, Nimesh D. Desai,

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Mohammad A. Zafar, MBBS, Emily A

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Aortic Root Replacement for Children With Loeys-Dietz Syndrome

Midterm Outcome of Valve-Sparing Aortic Root Replacement in Inherited Connective Tissue Disorders Hiroshi Tanaka, MD, PhD, Hitoshi Ogino, MD, PhD, Hitoshi.

Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement Tsuyoshi Kaneko, MD, Julius.

A. Thomas Pezzella, MD, Sari D

Early and Midterm Outcomes of Folding Valvuloplasty Without Leaflet Resection for Myxomatous Mitral Valve Disease Minoru Tabata, MD, MPH, Ravi K. Ghanta,

Transapical Aortic Valve Implantation in High-Risk Patients With Severe Aortic Valve Stenosis Augusto D'Onofrio, MD, Melissa Fusari, MD, Nicola Abbiate,

Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass

Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve Marjan Jahangiri, FRCS, Jean Claude Laborde,

Aortic Valve Replacement and Concomitant Procedures With the Perceval Valve: Results of European Trials Malakh Shrestha, MBBS, PhD, Thierry A. Folliguet,

Mitroflow Synergy Prostheses for Aortic Valve Replacement: 19 Years Experience With 1,516 Patients Kazutomo Minami, MD, Armin Zittermann, PhD, Sebastian.

Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Early Prognosis of Reduction Ascending Aortoplasty in Patients With Aortic Valve Disease: A Single Center’s Experience Shen Liu, MD, Yi Shi, MD, Ruofan.

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Ravi K. Ghanta, MD, Prem S. Shekar, MD, Siobhan McGurk, BS, Donna M

Wilson Y. Szeto, MD, Joseph E. Bavaria, MD, Frank W

The Impact of New Technology on Cardiothoracic Surgical Practice

Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? Asvin M. Ganapathi,

Risk of Valve-Related Events After Aortic Valve Repair

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Presentation transcript:

Reoperative Surgical Aortic Valve Replacement Versus Transcatheter Valve-in-Valve Replacement for Degenerated Bioprosthetic Aortic Valves Julius I. Ejiofor, MD, Maroun Yammine, MD, Morgan T. Harloff, MD, Siobhan McGurk, BS, Jochen D. Muehlschlegel, MD, MMS, Prem S. Shekar, MD, Lawrence H. Cohn, MD, Pinak Shah, MD, Tsuyoshi Kaneko, MD The Annals of Thoracic Surgery Volume 102, Issue 5, Pages 1452-1458 (November 2016) DOI: 10.1016/j.athoracsur.2016.05.086 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Consolidated Standards of Reporting Trials (CONSORT) flow diagram of inclusion and exclusion criteria used for patient selection. (AV = aortic valve; SAVR = surgical aortic valve replacement; STS = The Society for Thoracic Surgeons; TViV = transcatheter valve in valve replacement.) The Annals of Thoracic Surgery 2016 102, 1452-1458DOI: (10.1016/j.athoracsur.2016.05.086) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival curve for the 22 matched pairs by procedure type—surgical aortic valve replacement (SAVR [blue line]) and transcatheter valve in valve replacement (TViV [red line]) out to 3 years. The Annals of Thoracic Surgery 2016 102, 1452-1458DOI: (10.1016/j.athoracsur.2016.05.086) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions